Core Viewpoint - The trend of purchasing Directors and Officers Liability Insurance (D&O Insurance) among A-share listed companies continues to rise, with 272 companies announcing their intention to buy or have already purchased such insurance in 2024, maintaining a high level compared to previous years [1][3]. Group 1: Market Trends - In 2024, the number of A-share listed companies announcing D&O Insurance purchases is nearly equal to the total for 2023, indicating sustained interest [3]. - The manufacturing sector represents a significant portion of companies opting for D&O Insurance, with policy limits typically ranging from 50 million to 100 million yuan, and total premiums generally amounting to several hundred thousand yuan [3][4]. - The recent implementation of the new Company Law in July 2024 has established a legal framework for D&O Insurance, increasing the accountability of directors and executives [5]. Group 2: Reasons for Increased Demand - The new Company Law has strengthened the liability risks for directors and executives, prompting companies to seek D&O Insurance to mitigate these risks [5]. - Heightened regulatory scrutiny in the securities market and recent litigation cases have raised awareness of the potential risks faced by executives, further driving demand for D&O Insurance [5]. - The increasing number of companies purchasing D&O Insurance has created a demonstration effect, encouraging others to follow suit [5]. Group 3: Challenges in D&O Insurance Development - Despite the growing interest, challenges remain in the development of D&O Insurance, including insufficient localization of policy terms, lack of scientific pricing, and a shortage of specialized talent [7]. - The insurance market has historically been slow to adopt D&O Insurance, with many products inadequately tailored to align with domestic legal frameworks, leading to a mismatch between coverage and actual needs [7]. - The current lack of a comprehensive legal framework for executive liability in China adds uncertainty to the insurance companies' compensation responsibilities [7]. Group 4: Claims and Risk Management - There has been a noticeable increase in claims related to D&O Insurance, with several significant payouts reported in recent quarters, totaling over 8 million yuan [8]. - To address the rising claims, insurance companies need to enhance their risk assessment and management practices, ensuring that policy terms align with the actual risks faced by insured companies [8]. - Strengthening risk warning systems and improving information sharing within the industry are essential for enhancing pricing capabilities and risk management [8].

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：688573 证券简称：信宇人 公告编号：2025-016 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 根据中国证券监督管理委员会《上市公司监管指引第2号——上市公司募集资金管理和使用的监管要 求》和《上海证券交易所科创板上市公司自律监管指引第1号——规范运作》《上海证券交易所科创板 股票上市规则》等有关规定，深圳市信宇人科技股份有限公司（以下简称"公司"或"本公司"或"信宇人 公司"）编制了《2024年度募集资金存放与实际使用情况的专项报告》。具体如下： 一、募集资金基本情况 （一）实际募集资金金额和资金到账情况 经中国证券监督管理委员会《关于同意深圳市信宇人科技股份有限公司首次公开发行股票注册的批复》 （证监许可〔2023〕1408号）同意注册，并经上海证券交易所同意，公司由主承销商民生证券股份有限 公司采用向参与战略配售的投资者定向配售（以下简称"战略配售"）、网下向符合条件的投资者询价配 售（以下简称"网下发行"）、网上向持有上海市场非限售A股股份和非 ...